Hi muppet
The other factor that ADO has over BIo stocks that you mention is that it is both a new revenue and efficiency play for companies that adopt it.
The efficiency element is critical as it will make a business case easy to change your process if the cost to produce is significantly reduced.
Zabros posts on Bio separations is a great example.
Cheers TC
short med long term buy charts, page-22
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.2¢ |
Change
-0.002(8.33%) |
Mkt cap ! $56.77M | |||
| Open | High | Low | Value | Volume |
| 2.4¢ | 2.4¢ | 2.2¢ | $40.20K | 1.786M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 386453 | 2.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.3¢ | 248196 | 1 |
View Market Depth
| Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
| ADO (ASX) Chart |